The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 283-292

  Sesti Costa, Renata ^a   Silva, Grace K ^a   Proença Módena, José L ^a   Carlos, Daniela ^a   Silva, Maria L ^a   Alves Filho, José C ^a   Arruda, Eurico ^a   Liew, Foo Y ^b   Silva, João S ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; RECOMBINANT INTERLEUKIN 33; RECOMBINANT PROTEIN; ST2 PROTEIN; T1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B5; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; DEGRANULATION; DISEASE SEVERITY; MAST CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH2 CELL; VIRAL CLEARANCE; VIRUS LOAD; WEIGHT REDUCTION; WILD TYPE;

EID: 84879609207     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202806     Document Type: Article

References (50)

1. Racaniello, V. R. 2007. Picornaviridae: The viruses and their replication. In Field's Virology. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott, Williams & Wilkins, Philadelphia, PA, p. 796-838.
2. Ward, C. 1978. Severe arrhythmias in Coxsackievirus B3 myopericarditis. Arch. Dis. Child. 53: 174-176. (Pubitemid 8311512)
3. Whitton, J. L., C. T. Cornell, and R. Feuer. 2005. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3: 765-776. (Pubitemid 41518737)
4. Huber, S., and A. I. Ramsingh. 2004. Coxsackievirus-induced pancreatitis. Viral Immunol. 17: 358-369. (Pubitemid 39244758)
5. Mena, I., C. Fischer, J. R. Gebhard, C. M. Perry, S. Harkins, and J. L. Whitton. 2000. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271: 276-288. (Pubitemid 30461306)
6. Ramsingh, A. I., W. T. Lee, D. N. Collins, and L. E. Armstrong. 1999. T cells contribute to disease severity during coxsackievirus B4 infection. J. Virol. 73: 3080-3086. (Pubitemid 29135697)
7. Li, K., W. Xu, Q. Guo, Z. Jiang, P. Wang, Y. Yue, and S. Xiong. 2009. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 105: 353-364.
8. Kurowska-Stolarska, M., B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al. 2009. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183: 6469-6477.
9. Zaiss, M. M., M. Kurowska-Stolarska, C. Böhm, R. Gary, C. Scholtysek, B. Stolarski, J. Reilly, S. Kerr, N. L. Millar, T. Kamradt, et al. 2011. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J. Immunol. 186: 6097-6105.
10. Kurowska-Stolarska, M., P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, W. Niedbala, et al. 2008. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. [Published erratum appears in 2008 J Immunol. 181: 8170.] J. Immunol. 181: 4780-4790.
11. Allakhverdi, Z., D. E. Smith, M. R. Comeau, and G. Delespesse. 2007. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179: 2051-2054.
12. Moulin, D., O. Donzé, D. Talabot-Ayer, F. Mézin, G. Palmer, and C. Gabay. 2007. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40: 216-225.
13. Xu, D., H. R. Jiang, P. Kewin, Y. Li, R. Mu, A. R. Fraser, N. Pitman, M. Kurowska-Stolarska, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2008. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105: 10913-10918.
14. Enoksson, M., K. Lyberg, C. Möller-Westerberg, P. G. Fallon, G. Nilsson, and C. Lunderius-Andersson. 2011. Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 186: 2523-2528.
15. Pecaric-Petkovic, T., S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden. 2009. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
16. Suzukawa, M., M. Iikura, R. Koketsu, H. Nagase, C. Tamura, A. Komiya, S. Nakae, K. Matsushima, K. Ohta, K. Yamamoto, and M. Yamaguchi. 2008. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181: 5981-5989.
17. Cherry, W. B., J. Yoon, K. R. Bartemes, K. Iijima, and H. Kita. 2008. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121: 1484-1490. (Pubitemid 351787349)
18. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
19. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
20. Barksby, H. E., S. R. Lea, P. M. Preshaw, and J. J. Taylor. 2007. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149: 217-225. (Pubitemid 47063063)
21. Brint, E. K., D. Xu, H. Liu, A. Dunne, A. N. McKenzie, L. A. O'Neill, and F. Y. Liew. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5: 373-379. (Pubitemid 38500085)
22. Hepworth, M. R., E. Daniłowicz-Luebert, S. Rausch, M. Metz, C. Klotz, M. Maurer, and S. Hartmann. 2012. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc. Natl. Acad. Sci. USA 109: 6644-6649.
23. Mariano, F. S., F. R. Gutierrez, W. R. Pavanelli, C. M. Milanezi, K. A. Cavassani, A. P. Moreira, B. R. Ferreira, F. Q. Cunha, C. R. Cardoso, and J. S. Silva. 2008. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect. 10: 825-833.
24. Carlos, D., F. G. Frantz, D. A. Souza-Júnior, M. C. Jamur, C. Oliver, S. G. Ramos, V. F. Quesniaux, B. Ryffel, C. L. Silva, M. T. Bozza, and L. H. Faccioli. 2009. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect. 11: 770-778.
25. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
26. Misbah, S. A., G. P. Spickett, P. C. Ryba, J. M. Hockaday, J. S. Kroll, C. Sherwood, J. B. Kurtz, E. R. Moxon, and H. M. Chapel. 1992. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J. Clin. Immunol. 12: 266-270.
27. Mena, I., C. M. Perry, S. Harkins, F. Rodriguez, J. Gebhard, and J. L. Whitton. 1999. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 155: 1205-1215. (Pubitemid 29488928)
28. Moritz, D. R., H. R. Rodewald, J. Gheyselinck, and R. Klemenz. 1998. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161: 4866-4874. (Pubitemid 28492065)
29. Xu, D., H. R. Jiang, Y. Li, P. N. Pushparaj, M. Kurowska-Stolarska, B. P. Leung, R. Mu, H. K. Tay, A. N. McKenzie, I. B. McInnes, et al. 2010. IL-33 exacerbates autoantibody-induced arthritis. J. Immunol. 184: 2620-2626.
30. Hsu, C. L., C. V. Neilsen, and P. J. Bryce. 2010. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 5: e11944.
31. Monticelli, L. A., G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler, T. A. Doering, J. M. Angelosanto, B. J. Laidlaw, C. Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12: 1045-1054.
32. Scumpia, P. O., M. J. Delano, K. M. Kelly-Scumpia, J. S. Weinstein, J. L. Wynn, R. D. Winfield, C. Xia, C. S. Chung, A. Ayala, M. A. Atkinson, et al. 2007. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 110: 3673-3681. (Pubitemid 350159636)
33. Ehtisham, S., N. P. Sunil-Chandra, and A. A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67: 5247-5252. (Pubitemid 23241355)
34. Fung-Leung, W. P., T. M. Kündig, R. M. Zinkernagel, and T. W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174: 1425-1429.
35. + T cell responses. Science 335: 984-989.
36. Hühn, M. H., M. Hultcrantz, K. Lind, H. G. Ljunggren, K. J. Malmberg, and M. Flodström-Tullberg. 2008. IFN-gamma production dominates the early human natural killer cell response to Coxsackievirus infection. Cell. Microbiol. 10: 426-436.
37. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002. (Pubitemid 44330250)
38. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786. (Pubitemid 40563184)
39. Ostrowski, S. E., A. A. Reilly, D. N. Collins, and A. I. Ramsingh. 2004. Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis. J. Virol. 78: 8229-8237. (Pubitemid 38944306)
40. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35. (Pubitemid 37328697)
41. Benoit, M., B. Desnues, and J. L. Mege. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181: 3733-3739.
42. Jiang, H. R., M. Milovanović, D. Allan, W. Niedbala, A. G. Besnard, S. Y. Fukada, J. C. Alves-Filho, D. Togbe, C. S. Goodyear, C. Linington, et al. 2012. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur. J. Immunol. 42: 1804-14.
43. Liu, G., H. Ma, L. Qiu, L. Li, Y. Cao, J. Ma, and Y. Zhao. 2011. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89: 130-142.
44. Zhang, M. Z., B. Yao, S. Yang, L. Jiang, S. Wang, X. Fan, H. Yin, K. Wong, T. Miyazawa, J. Chen, et al. 2012. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122: 4519-4532.
45. Villalta, S. A., B. Deng, C. Rinaldi, M. Wehling-Henricks, and J. G. Tidball. 2011. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol. 187: 5419-5428.
46. Schwartz, M. 2010. "Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Brain Behav. Immun. 24: 1054-1057.
47. Chang, Y. J., H. Y. Kim, L. A. Albacker, N. Baumgarth, A. N. McKenzie, D. E. Smith, R. H. Dekruyff, and D. T. Umetsu. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12: 631-638.
48. Lowenfels, A. B., P. Maisonneuve, and P. G. Lankisch. 1999. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol. Clin. North Am. 28: 673-685, x. (Pubitemid 29439470)
49. Talamini, G., M. Falconi, C. Bassi, N. Sartori, R. Salvia, E. Caldiron, L. Frulloni, V. Di Francesco, B. Vaona, P. Bovo, et al. 1999. Incidence of cancer in the course of chronic pancreatitis. Am. J. Gastroenterol. 94: 1253-1260. (Pubitemid 29214638)
50. Ouziel, R., Gustot, T., Moreno, C., Arvanitakis, M., Degré, D., Trépo, E., Quertinmont, E., Vercruysse, V., Demetter, P., Le Moine, O., et al. 2012. The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. Am. J. Pathol. 180: 2330-9. São Paulo